⌘K

Home/Filings/4/0001628280-25-031646

4//SEC Filing

Lo Andrew 4

Accession 0001628280-25-031646

CIK 0001703057other

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 5:30 PM ET

Size

5.5 KB

Accession

0001628280-25-031646

Insider Transaction Report

Form 4

Period: 2025-06-12

AbCellera Biologics Inc.ABCL

Director

Transactions

Award
Share option (right to buy)
2025-06-12+238,864→ 541,354 total
Exercise: $3.15From: 2026-06-11Exp: 2035-06-12→ Common Shares (238,864 underlying)

Footnotes (1)

[F1]The shares subject to such option vest and become exercisable at the 2026 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date.

Documents

1 file

4
wk-form4_1750109427.xmlPrimary
FORM 4

Issuer

AbCellera Biologics Inc.

CIK 0001703057

Entity typeother

Related Parties

1

filerCIK 0001679076

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 5:30 PM ET
Size: 5.5 KB

View on SEC.gov